Trial Profile
A retrospective study assessing long term effect of Cabergoline on macroprolactinoma and factors associated with remission after withdrawal.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Oct 2017
Price :
$35
*
At a glance
- Drugs Cabergoline (Primary)
- Indications Prolactinoma
- Focus Therapeutic Use
- 10 Oct 2017 New trial record